MK-8262

potential best-in-class CETP inh. (<1 mg QD)

completed Ph. I in HV; discont. as backup

from anacetrapib

Journal of Medicinal Chemistry

Merck & Co., Kenilworth, NJ, USA

The Merck CETP inhibitor backup, MK-8262, is potential best-in-class CETP inhibitor, which was only discontinued as a backup due to the success of its predecessor, anacetrapib in Ph. III. Reviewer Kim…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.